CNM Publications 2009 to Present

Selected Publications

Found 106 results
Author Title Type [ Year(Asc)]
Sturgill ER, Aoki K, Lopez PHH, Colacurcio D, Vajn K, Lorenzini I, Majić S, Yang WHo, Heffer M, Tiemeyer M et al..  2012.  Biosynthesis of the major brain gangliosides GD1a and GT1b.. Glycobiology. 22(10):1289-301.
Luni C, Marth JD, Doyle FJ.  2012.  Computational modeling of glucose transport in pancreatic β-cells identifies metabolic thresholds and therapeutic targets in diabetes.. PLoS One. 7(12):e53130.
Yang WHo, Nussbaum C, Grewal PK, Marth JD, Sperandio M.  2012.  Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.. Blood. 120(5):1015-26.
Karmali PPrakash, Chao Y, Park J-H, Sailor MJ, Ruoslahti E, Esener SC, Simberg D.  2012.  Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles.. Mol Pharm. 9(3):539-45.
Teesalu T, Sugahara KN, Ruoslahti E.  2012.  Mapping of vascular ZIP codes by phage display.. Methods Enzymol. 503:35-56.
Ruoslahti E.  2012.  Peptides as targeting elements and tissue penetration devices for nanoparticles.. Adv Mater. 24(28):3747-56.
Chao Y, Makale M, Karmali PPrakash, Sharikov Y, Tsigelny I, Merkulov S, Kesari S, Wrasidlo W, Ruoslahti E, Simberg D.  2012.  Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains.. Bioconjug Chem. 23(5):1003-9.
Erster O, Thomas JM, Hamzah J, Jabaiah AM, Getz JA, Schoep TD, Hall SS, Ruoslahti E, Daugherty PS.  2012.  Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases.. J Control Release. 161(3):804-12.
Sawada J, Urakami T, Li F, Urakami A, Zhu W, Fukuda M, Li DY, Ruoslahti E, Komatsu M.  2012.  Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels.. Cancer Cell. 22(2):235-49.
Ren Y, Cheung HWing, von Maltzhan G, Agrawal A, Cowley GS, Weir BA, Boehm JS, Tamayo P, Karst AM, Liu JF et al..  2012.  Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4.. Sci Transl Med. 4(147):147ra112.
Brunquell C, Biliran H, Jennings S, Ireland SKale, Chen R, Ruoslahti E.  2012.  TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.. Mol Cancer Res. 10(11):1482-95.
Haspel N, Zanuy D, Nussinov R, Teesalu T, Ruoslahti E, Alemán C.  2011.  Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.. Biochemistry. 50(10):1755-62.
Kinsella JM, Ananda S, Andrew JS, Grondek JF, Chien M-P, Scadeng M, Gianneschi NC, Ruoslahti E, Sailor MJ.  2011.  Enhanced magnetic resonance contrast of Fe₃O₄ nanoparticles trapped in a porous silicon nanoparticle host.. Adv Mater. 23(36):H248-53.
Ismail MNazri, Stone EL, Panico M, Lee SHo, Luu Y, Ramirez K, Ho SB, Fukuda M, Marth JD, Haslam SM et al..  2011.  High-sensitivity O-glycomic analysis of mice deficient in core 2 {beta}1,6-N-acetylglucosaminyltransferases.. Glycobiology. 21(1):82-98.
Fraikin J-L, Teesalu T, McKenney CM, Ruoslahti E, Cleland AN.  2011.  A high-throughput label-free nanoparticle analyser.. Nat Nanotechnol. 6(5):308-13.
Karmali PPrakash, Brunquell C, Tram H, Ireland SKale, Ruoslahti E, Biliran H.  2011.  Metastasis of tumor cells is enhanced by downregulation of Bit1.. PLoS One. 6(8):e23840.
Sánchez-Martín D, Cuesta AM, Fogal V, Ruoslahti E, Álvarez-Vallina L.  2011.  The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies.. J Biol Chem. 286(7):5197-203.
von Maltzahn G, Park J-H, Lin KY, Singh N, Schwöppe C, Mesters R, Berdel WE, Ruoslahti E, Sailor MJ, Bhatia SN.  2011.  Nanoparticles that communicate in vivo to amplify tumour targeting.. Nat Mater. 10(7):545-52.
Ohtsubo K, Chen MZ, Olefsky JM, Marth JD.  2011.  Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.. Nat Med. 17(9):1067-75.
Urakami T, Järvinen TAH, Toba M, Sawada J, Ambalavanan N, Mann D, McMurtry I, Oka M, Ruoslahti E, Komatsu M.  2011.  Peptide-directed highly selective targeting of pulmonary arterial hypertension.. Am J Pathol. 178(6):2489-95.
Yang Y-H, Rajaiah R, Ruoslahti E, Moudgil KD.  2011.  Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.. Proc Natl Acad Sci U S A. 108(31):12857-62.
Wang J, Liu Y, Teesalu T, Sugahara KN, Kotamrajua VRamana, Adams JD, Ferguson BS, Gong Q, Oh SSoo, Csordas AT et al..  2011.  Selection of phage-displayed peptides on live adherent cells in microfluidic channels.. Proc Natl Acad Sci U S A. 108(17):6909-14.
Hamzah J, Kotamraju VR, Seo JW, Agemy L, Fogal V, Mahakian LM, Peters D, Roth L, M Gagnon KJ, Ferrara KW et al..  2011.  Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice.. Proc Natl Acad Sci U S A. 108(17):7154-9.
Agemy L, Friedmann-Morvinski D, Kotamraju VRamana, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E.  2011.  Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma.. Proc Natl Acad Sci U S A. 108(42):17450-5.
Kinsella JM, Jimenez RE, Karmali PP, Rush AM, V Kotamraju R, Gianneschi NC, Ruoslahti E, Stupack D, Sailor MJ.  2011.  X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles.. Angew Chem Int Ed Engl. 50(51):12308-11.